TrialWorld journal of urology2020

Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.